We are live on ! Find out more
UNCY icon

Unicycive Therapeutics

16 hedge funds and large institutions have $11.3M invested in Unicycive Therapeutics in 2023 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 3

0% more funds holding

Funds holding: 16 → 16 (0)

0% more first-time investments, than exits

New positions opened: 3 | Existing positions closed: 3

3.34% less ownership

Funds ownership: 40.84% → 37.5% (-3.3%)

85% less capital inflows, than outflows

Capital inflows: $131K | Capital outflows: $897K

Holders
16
Holders Change
–
Holders Change %
0%
% of All Funds
0.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
3
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

UNCY Hedge Fund Activity: Q4 2023 in Review

16 of the 6,876 institutional investors tracked by Wall St. Rank reported a position in Unicycive Therapeutics (UNCY) for Q4 2023, worth a combined $11.3M — down 7.4% from $12.2M a quarter earlier.

Fund positioning in UNCY was balanced in Q4 2023: 3 funds opened new positions, 3 closed out, 4 added to existing stakes and 3 trimmed.

The largest buyer was Geode Capital Management, adding an estimated $76.3K. The largest seller was BVF Inc, cutting an estimated $847K.

  • 16 institutional investors held Unicycive Therapeutics (UNCY) as of Q4 2023, unchanged from Q3 2023.
  • Funds reported $11.3M of Unicycive Therapeutics stock for Q4 2023, down 7.4% quarter-over-quarter.
  • 3 funds opened new Unicycive Therapeutics positions in Q4 2023 and 3 closed out, a net change of 0 holders.
  • The largest Unicycive Therapeutics buyer in Q4 2023 was Geode Capital Management, an estimated $76.3K added.
  • The largest Unicycive Therapeutics seller in Q4 2023 was BVF Inc, an estimated $847K sold.

Based on aggregated 13F filings for Q4 2023.